Earnings Recaps

Browse reported earnings of the most popular stocks

May 29, 2026 May 28, 2026 May 27, 2026 May 26, 2026 May 24, 2026 May 23, 2026 May 22, 2026 May 21, 2026 May 20, 2026 May 19, 2026 May 18, 2026 May 17, 2026 May 16, 2026 May 15, 2026 May 14, 2026 May 13, 2026 May 12, 2026 May 11, 2026 May 10, 2026 May 9, 2026 May 8, 2026 May 7, 2026 May 6, 2026 May 5, 2026 May 4, 2026 May 3, 2026 May 2, 2026 May 1, 2026 Apr 30, 2026 Apr 29, 2026 Apr 23, 2026 Apr 22, 2026 Apr 21, 2026 Apr 20, 2026 Apr 18, 2026 Apr 17, 2026 Apr 16, 2026 Apr 15, 2026 Apr 14, 2026 Apr 13, 2026 Apr 10, 2026 Apr 9, 2026 Apr 8, 2026 Apr 7, 2026 Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026 Jan 7, 2026 Jan 6, 2026 Dec 19, 2025 Dec 18, 2025 Dec 17, 2025 Dec 12, 2025 Dec 11, 2025 Dec 10, 2025 Dec 9, 2025 Dec 6, 2025 Dec 5, 2025 Dec 4, 2025 Dec 3, 2025 Dec 2, 2025 Dec 1, 2025 Nov 27, 2025 Nov 26, 2025 Nov 25, 2025 Nov 24, 2025 Nov 23, 2025 Nov 21, 2025 Nov 20, 2025 Nov 19, 2025 Nov 18, 2025 Nov 17, 2025 Nov 15, 2025 Nov 14, 2025 Nov 13, 2025 Nov 12, 2025 Nov 11, 2025 Nov 10, 2025 Nov 9, 2025 Nov 8, 2025 Nov 7, 2025 Nov 6, 2025 Nov 5, 2025 Nov 4, 2025 Nov 1, 2025 Oct 31, 2025 Oct 30, 2025 Oct 29, 2025 Oct 28, 2025 Oct 27, 2025 Oct 25, 2025 Oct 24, 2025 Oct 23, 2025 Oct 22, 2025 Oct 21, 2025 Oct 17, 2025 Oct 16, 2025 Oct 15, 2025 Oct 14, 2025 Oct 9, 2025 Oct 8, 2025 Oct 7, 2025 Sep 25, 2025 Sep 23, 2025 Sep 17, 2025
13 companies Today

Agilent Technologies, Inc.

A Q2 2026
Reported: 2026-05-29

Shares rose 17.6% on strong revenue growth, margin expansion, and double-digit EPS growth that materially beat expectations, driven by broad-based strength across end markets and continued replacement cycle momentum.

Key takeaways
  • Reported $1.83 billion in revenue, up 6.3% core year-over-year, exceeding the high end of guidance by 80 basis points.
  • Operating margin expanded 130 basis points year-over-year to 26.4%, surpassing guidance despite challenging macro and geopolitical conditions.
  • EPS of $1.49 grew 14% year-over-year and topped guidance by $0.07.
  • Balanced growth across key segments: Pharma +6%, Chemical & Advanced Materials +8%, Diagnostics & Clinical +11%, and Forensics over +50%, supported by significant new contracts and market share gains.
  • Instrument revenue saw high single-digit growth with strong replacement cycle momentum and book-to-bill above 1 for the ninth consecutive quarter.

Abercrombie & Fitch Co.

ANF Q1 2026
Reported: 2026-05-29

Abercrombie & Fitch shares rose nearly 10% following a quarter that beat expectations on operating income and earnings per share, driven by solid net sales growth in the Americas and APAC despite headwinds in EMEA.

Key takeaways
  • Net sales reached a record $1.1 billion, up 2% year-over-year, in line with company expectations.
  • Operating margin improved to 8%, exceeding plans due to slightly lower tariff rates.
  • Earnings per share came in at $1.47, above the expected range.
  • Regional performance was mixed: Americas up 3%, APAC grew 24%, while EMEA declined 10% mainly from Middle East and other European markets.
  • The company returned $105 million to shareholders via share repurchases, equal to 3% of shares outstanding at the start of the year.

Bath & Body Works Inc.

BBWI Q1 2026
Reported: 2026-05-29

The stock rose 14.8% following Q1 results, driven by better-than-expected sales and earnings per share despite ongoing pressure in underlying business trends. Investor enthusiasm appears tied to early signs of success from the company’s innovation and brand revitalization strategy, with confidence growing in long-term transformation plans.

Key takeaways
  • Net sales declined 3% but still came in above expectations, indicating less softness than feared.
  • Adjusted EPS of $0.32 also beat estimates, contributing to positive investor reaction.
  • Strong early consumer acceptance of new product launches highlighted by double-digit increases in average unit retail and SKU productivity for the new formulas.
  • Body Care segment underperformed due to planned assortment changes and overcorrection on luxury franchise assortment, though swift remediation efforts are underway.
  • Management reaffirmed full year 2026 sales and EPS guidance, emphasizing this is an early phase of a multi-year turnaround focused on product innovation and brand modernization.

Community

See what investors are trading, holding, and sharing

🌐
All
📈
Stock
📊
ETF
🏦
Mutual Fund
🪙
Crypto
💱
Forex
# Asset Price Community % Type Currency Sector
Loading...